Interplay between Gut Microbiota and Antimicrobial Resistance
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 241
Special Issue Editors
Interests: human oral and gut microbiome; antibiotic-resistant bacteria; Gramnegative bacteria; anaerobes; effects of probiotics and antibiotics; LPS; horizontal gene transfer; plasmids; NGS
Special Issue Information
Dear Colleagues,
The gut microbiota is a stable and diverse ecosystem that provides important benefits to human health, such as promoting innate and adaptative immunity, synthesizing certain vitamins and amino acids, and protecting against pathogens. Antibiotic treatment, a crucial therapeutic intervention, may disrupt taxonomic species within the gut microbiota, creating opportunities for pathogen colonization and subsequently impacting host metabolism and physiology. This imbalance, commonly termed "dysbiosis", opens the door to the potential colonization by antimicrobial-resistant bacteria and increases the load of antimicrobial resistance genes (ARGs). Antimicrobial resistance (AMR) substantially threatens public health, resembling a silent pandemic. This challenge necessitates targeted interventions within the human health, food production, animal and environmental sectors, requiring a coordinated and intersectoral approach. The gut microbiome, a critical reservoir for ARGs, underscores the urgency of understanding and addressing this intricate interplay to preserve human health.
This Special Issue aims to provide articles highlighting current issues in the interplay between the gut microbiota and antimicrobial resistance research. As the Guest Editor, I invite you to submit research articles, review articles and short communications focusing on the gut microbiome and antimicrobial-resistant bacteria, notably those exploring dysbiosis induced by antibiotics. Additionally, submissions discussing antibiotic resistance mechanisms and possible treatments to address this phenomenon are highly encouraged.
Dr. Miriam R. Fernandes
Dr. Viviane Nakano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotic resistance genes (ARGs)
- horizontal gene transfer
- antimicrobial resistance mechanisms
- gut microbiota
- anaerobes
- probiotics
- dysbiosis
- fecal microbiota transplantation (FMT)
- One Health
